Advertisement
Person › Details
Karsten Lindhardt (Biograil ApS)
Lindhardt, Karsten (Biograil 202001 CEO before Egalet + Novo Nordisk + Ferring + Prosidion + Curalogic)
Organisation | Biograil ApS | |
Product | oral drug delivery technology | |
Record changed: 2020-06-08 |
Advertisement
More documents for Karsten Lindhardt
- [1] Biograil ApS. (4/30/20). "Press Release: Biograil Announces Sanner Ventures Has Joined Investor Syndicate". Copenhagen....
- [2] High-Tech Gründerfonds Management GmbH. (1/15/20). "Press Release: Biograil Secures Seed Funding for Oral Delivery Device with Potential to Transform Market for Injectables"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top